Topic

California

A collection of 429 issues

Work With Your Doctor to Get Retevmo (selpercatinib) Covered by Humana in California: Templates, Timelines & Appeal Scripts

Quick Answer: Getting Retevmo (selpercatinib) Covered by Humana in California Humana Medicare Advantage requires prior authorization for Retevmo (selpercatinib) for RET fusion-positive cancers. Your oncologist must submit documentation proving RET alteration status through Evolent's portal or by calling 844-926-4528. If denied, you have 65 days to appeal and
6 min read

If Zanzalintinib (XL092) Isn't Approved by UnitedHealthcare in California: Formulary Alternatives & Exception Paths

Answer Box: Getting Zanzalintinib (XL092) Covered by UnitedHealthcare in California Zanzalintinib (XL092) is investigational and typically not covered by UnitedHealthcare outside clinical trials. Your fastest paths: 1) Request compassionate use through Exelixis (drug provided free), 2) Try covered multi-target TKI alternatives like cabozantinib or lenvatinib with prior authorization, or 3)
5 min read

How to Get Xywav (Ca/Mg/K/Na oxybates) Covered by Cigna in California: Prior Authorization, Appeals, and Cost-Saving Strategies

Answer Box: Getting Xywav Covered by Cigna in California Cigna requires prior authorization for Xywav with strict criteria: confirmed narcolepsy/idiopathic hypersomnia diagnosis, sleep studies, specialist prescription, failed dextroamphetamine trial, and REMS enrollment. First step: Have your sleep specialist submit PA request with complete documentation to Cigna/Express Scripts. If
6 min read

How to Get Orkambi (lumacaftor/ivacaftor) Covered by Cigna in California: Appeals Timeline and Documentation Guide

Answer Box: Getting Orkambi Covered by Cigna in California Fastest Path: Submit prior authorization with genetic test results showing F508del homozygosity, CF diagnosis documentation, and specialist prescription. If denied, file internal appeal within 180 days, then request California Independent Medical Review (IMR) through DMHC. Success rate for IMR appeals is
6 min read